Institut Català de la Salut
[Esmel-Vilomara R] Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Cardiologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Pediatric Cardiology, Hospital de la Santa Creu i Sant Pau, Sant Pau Research Institute (IR Sant Pau), Barcelona, Spain. [Riaza L] Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Àrea de Radiologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Dolader P, Sabaté-Rotés A, Rosés-Noguer F, Gran F] Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Cardiologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Rodríguez-Santiago B] Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Clinical and Molecular Genetics, Hospital de la Santa Creu i Sant Pau, Sant Pau Research Institute (IR Sant Pau) and Center for Biomedical Network Research on Rare Diseases (CIBERER), Barcelona, Spain. [Lasa-Aranzasti A] Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Àrea de Genètica Clínica i Molecular, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Muñoz-Cabello P, Fernández-Álvarez P] Àrea de Genètica Clínica i Molecular, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Figueras-Coll M] Servei de Cardiologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Pediatric Cardiology, Hospital Universitari Doctor Josep Trueta, Girona, Spain. [Bianco L] Pediatric Cardiology, Ospedale Pediatrico Bambino Gesù, Rome, Italy. Pediatric Cardiology, Hospital General deGranollers, Granollers, Spain. [Bueno-Gómez A] Pediatric Cardiology, Hospital General de Granollers, Granollers, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-05-27T06:05:13Z
2025-05-27T06:05:13Z
2025-08-01
Adolescents; Cardiac magnetic resonance; Myocarditis
Adolescents; Ressonància magnètica cardíaca; Miocarditis
Adolescentes; Resonancia magnética cardíaca; Miocarditis
Background Myocarditis has traditionally been considered an acquired condition, but recent evidence suggests a genetic contribution, primarily in complicated cases. Data on pediatric uncomplicated or infarct-like myocarditis remain scarce. This study aimed to assess the prevalence of pathogenic or likely pathogenic (P/LP) variants in adolescents with infarct-like myocarditis and their association with clinical and imaging findings. Methods This prospective, multicenter study included 30 adolescents diagnosed with infarct-like myocarditis across five hospitals in Catalunya, Spain (2016–2024). Diagnosis was confirmed using the 2018 Lake Louise Criteria on cardiac magnetic resonance imaging (CMR). Follow-up CMR was performed at 12 months, and genetic testing was conducted using a next-generation sequencing panel targeting 174 genes associated with inherited cardiac diseases. Results P/LP variants in cardiomyopathy-associated genes were identified in 22.2 % of patients. Baseline CMR showed no significant differences in ventricular function or LGE extent, but a ring-like LGE pattern was significantly associated with genetic findings (p = 0.025), while septal involvement showed a p-value of 0.056. Over a median follow-up of 3 years (IQR 2–7), 9 patients (30 %) experienced recurrent myocarditis, more frequently in genetic-positive patients (66.7 % vs. 23.8 %). At 12 months, genetic-positive patients exhibited a greater LGE burden (p = 0.047) and persistent myocardial edema on T2-STIR (p = 0.009), suggesting ongoing myocardial remodeling. Conclusions The high prevalence of P/LP variants in infarct-like myocarditis highlights the need for genetic testing, particularly in patients with a ring-like LGE pattern or septal involvement. Persistent CMR abnormalities and symptomatic recurrences in genetic-positive cases support long-term monitoring, even in seemingly uncomplicated presentations.
Article
Published version
English
Cromosomes humans - Anomalies - Diagnòstic; Miocarditis - Imatgeria per ressonància magnètica; Miocarditis - Aspectes genètics; Adolescents; DISEASES::Cardiovascular Diseases::Heart Diseases::Cardiomyopathies::Myocarditis; Other subheadings::Other subheadings::Other subheadings::/genetics; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Tomography::Magnetic Resonance Imaging::Magnetic Resonance Imaging, Cine; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Genetic Testing; NAMED GROUPS::Persons::Age Groups::Adolescent; ENFERMEDADES::enfermedades cardiovasculares::enfermedades cardíacas::miocardiopatías::miocarditis; Otros calificadores::Otros calificadores::Otros calificadores::/genética; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::tomografía::imagen por resonancia magnética::imagen de cinerresonancia magnética; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::técnicas de laboratorio clínico::pruebas genéticas; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::adolescente
Elsevier
International Journal of Cardiology;432
https://doi.org/10.1016/j.ijcard.2025.133255
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HG [170]
Articles científics - HVH [3416]